BridgeBio Pharma (BBIO) Free Cash Flow (2018 - 2026)
BridgeBio Pharma (BBIO) free cash flow from Sep 30, 2018 to Mar 31, 2026. The TTM BridgeBio Pharma (BBIO) free cash flow is -$445M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
BridgeBio Pharma (BBIO) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -11.10% |
| 3 Years TTM | +3.02% |
| 5 Years TTM | -1.15% |
| All Time TTM | +15.12% |
Annual Free Cash Flow change of BridgeBio Pharma (BBIO)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$197M | -55.85% |
| 2025 | -$447M | -14.31% |
| 2024 | -$522M | -1.39% |
| 2023 | -$529M | +24.68% |
| 2022 | -$424M | -16.99% |
| 2021 | -$511M | +25.53% |
| 2020 | -$407M | +58.93% |
| 2019 | -$256M | +84.58% |
| 2018 | -$139M | +239.00% |
| 2017 | -$41M | N/A |
Comparison BridgeBio Pharma (BBIO) five years free cash flow CAGR with competitors
BridgeBio Pharma (BBIO) five years free cash flow CAGR is -1.15%.